Hypertrophy

You have accessRestricted access
Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy
Ke-Qiong Deng, Guang-Nian Zhao, Zhihua Wang, Jing Fang, Zhou Jiang, Jun Gong, Feng-Juan Yan, Xue-Yong Zhu, Peng Zhang, Zhi-Gang She and Hongliang Li

Circulation. 2018;137:1486-1504, originally published December 11, 2017
https://doi.org/10.1161/CIRCULATIONAHA.117.031659

Download PDF
You have accessRestricted access
Ventricular Tachycardia and Electrocardiographic ST-Segment–Elevation Myocardial Infarction Without Coronary Artery Disease
Christina A. Zauner, J. Warren Holshouser and Laszlo Littmann

Circulation. 2018;137:1287-1289, originally published March 19, 2018
https://doi.org/10.1161/CIRCULATIONAHA.118.033664

Download PDF
You have accessRestricted access
Response by Soliman et al to Letters Regarding Article, “Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)”
Elsayed Z. Soliman, Walter T. Ambrosius and Cora E. Lewis

Circulation. 2018;137:1300-1301, originally published March 19, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.031849

Download PDF
You have accessRestricted access
Letter by Lewis et al Regarding Article, “Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)”
Gavin A. Lewis, Erik B. Schelbert and Christopher A. Miller

Circulation. 2018;137:1297-1298, originally published March 19, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.031123

Download PDF
You have accessRestricted access
Letter by Tsuda Regarding Article, “A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure”
Kazushi Tsuda

Circulation. 2018;137:1198-1199, originally published March 12, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.030714

Download PDF
You have accessRestricted access
Response by Aubdool et al to Letters Regarding Article, “A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure”
Aisah A. Aubdool, Fulye Argunhan, Pratish Thakore and Susan D. Brain

Circulation. 2018;137:1201-1202, originally published March 12, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.031848

Download PDF
You have accessRestricted access
Predicting the Future in Hypertrophic Cardiomyopathy
Carolyn Y. Ho and Mark S. Link

Circulation. 2018;137:1024-1026, originally published March 5, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.032627

Download PDF
You have accessRestricted access
Exercise and Hypertrophic CardiomyopathyTime for a Change of Heart
Sara Saberi and Sharlene M. Day

Circulation. 2018;137:419-421, originally published January 29, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.029989

Download PDF
You have accessRestricted access
Left Ventricular Hypertrophy RevisitedCell and Matrix Expansion Have Disease-Specific Relationships
Thomas A. Treibel, Rebecca Kozor, Katia Menacho, Silvia Castelletti, Heerajnarain Bulluck, Stefania Rosmini, Sabrina Nordin, Viviana Maestrini, Marianna Fontana and James C. Moon

Circulation. 2017;136:2519-2521, originally published December 18, 2017
https://doi.org/10.1161/CIRCULATIONAHA.117.029895

Download PDF
You have accessRestricted access
SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac HypertrophyUniversity of Michigan
Xiaoqiang Tang, Xiao-Feng Chen, Nan-Yu Wang, Xiao-Man Wang, Shu-Ting Liang, Wei Zheng, Yun-Biao Lu, Xiang Zhao, De-Long Hao, Zhu-Qin Zhang, Ming-Hui Zou, De-Pei Liu and Hou-Zao Chen

Circulation. 2017;136:2051-2067, originally published September 25, 2017
https://doi.org/10.1161/CIRCULATIONAHA.117.028728

Download PDF

Header Publisher Menu

Circulation

Hypertrophy

Pages

Current Issue

Search This Journal

Related Collections

Customer Service

About Us

Our Sites

Take Action

Online Communities